Prescription Drugs

The program has become a revenue-generating tool for hospitals rather than a mechanism to support low-income Americans

Exorbitant drug prices burden American patients and taxpayers in an unfree market

The PREVAIL Act would unnecessarily delay cheaper drugs from entering the market

Are Medicare’s drug pricing negotiations working?

One small change would give CMS the leverage to drive drug pricing down and improve costs for patients

Today’s U.S. patent system does not always live up to its idealistic portrayal

Reducing prescription drug prices has long been a goal of Democrats in Congress and the White House. Has that changed?

A proposed bipartisan bill aims to curb this practice